Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Pregnancy and Thyroid Function

임신과 갑상선 기능의 평가

  • Park, Chang-Eun (Department of Biomedical Laboratory Science, Molecular Diagnostics Research Institute, Namseoul University)
  • 박창은 (남서울대학교 임상병리학과, 분자진단연구소)
  • Received : 2018.01.20
  • Accepted : 2018.02.04
  • Published : 2018.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

During early pregnancy, before the development of a functioning thyroid gland, thyroid stimulating hormone (TSH) is a very sensitive marker of thyroid dysfunction during pregnancy. Normal values have been modified during gestation with a downward shift. The fetus is influenced by the TSH supplied by the mother. TSH and free thyroxine (FT4) concentrations vary during pregnancy and conventional units can vary between laboratories. A downward shift of the TSH reference range occurs during pregnancy, with a decrease in both the lower and upper limits of maternal TSH, relative to the typical non-pregnant TSH reference range. Each laboratory produces its own reference TSH and FT4 concentrations because there are many different assays that yield different results in pregnancy. Therefore, automated immunoassays used for serum FT4 analysis are still used widely, but the important considerations discussed above must be noted. The use of population-based, trimester-specific reference ranges remains the best way to handle this issue The slight downward shift in the upper reference range of TSH occurring in the latter first trimester (7~12 weeks) of pregnancy, typically not observed prior to 7 weeks. Their use indicates high or low levels in a quantitative manner independent of the reference ranges. These data highlight the importance of calculating population-based pregnancy-specific thyroid parameter reference intervals. A precision medicine initiative in this area will require the collection and analysis of a large number of genetic, biological, psychosocial, and environmental variables in large cohorts of individuals. Large prospective randomized controlled trials will be needed to resolve these controversies.

갑상선의 기능적 발달 이전인 임신초기에 갑상선자극호르몬은 갑상선 장애 및 임신 동안 매우 민감한 지표이다. 임신동안 정상수준은 감소 변화를 보이는 것은 모체로부터 태아가 받는 갑상선호르몬의 영향이다. 갑상선자극호르몬과 유리 티록신의 농도는 임신동안 및 검사실간에 다양하게 보고된다. 갑상선자극호르몬의 참고치는 비임신군에 비하면 상한값과 하한값의 참고범위의 감소가 임신동안 보인다. 각 실험실은 임신 중에 다른 결과를 산출하는 호르몬 분석법과 일부 자체 기준에 맞는 혈중 농도를 산출한다. 따라서, 혈청 유리 티록신 분석에 사용되는 자동화 된 면역 분석법은 여전히 널리 사용되고 있지만 고려할 사항이 있다. 집단 기준, 삼분위 기간별 특이적 참고범위 사용은 문제해결의 최상의 방법이다. 임신 7~12주에 발생하는 호르몬의 하향은 7주 이전에는 보이지 않아 참고범위의 개별적 정량적으로 상승 및 하강을 보여준다. 본 연구에서는 집단별과 임신 특이적 갑상선 매개 변수의 참조범위에 대한 산출 중요성을 강조한다. 정밀의학 의 도래에 있어서 많은 개체의 유전적, 생물학적, 심리사회학적, 환경적 변수를 수집하고 분석이 필요하다. 이러한 논쟁을 해결하기 위해서는 다량의 전향적인 무작위 통제 연구가 필요하다.

Keywords

References

  1. Jackson I. The thyroid axis and depression. Thyroid. 1998;8(10):951-956. https://doi.org/10.1089/thy.1998.8.951
  2. Pop V, Maartens L, Leusink G, van Son M, Knottnerus A, Ward A, et al. Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab. 1998;83(9):3194-3197. https://doi.org/10.1210/jc.83.9.3194
  3. Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy-are these the cause of the problem? Best Pract Res Clin Endocrinol Metab. 2010;24(4):515-525. https://doi.org/10.1016/j.beem.2010.05.006
  4. Laurberg P, Andersen SL, Hindersson P, Nohr EA, Olsen J. Dynamics and predictors of serum TSH and fT4 reference limits in early pregnancy: a study within the Danish National Birth Cohort. J Clin Endocrinol Metab. 2016;101(6):2484-2492. https://doi.org/10.1210/jc.2016-1387
  5. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702-705. https://doi.org/10.1210/er.2009-0041
  6. Lazarus JH, Smyth PPA. Iodine deficiency in pregnancy: iodine deficiency and supplementation in pregnancy. In: Preedy Victor R., Burrow Gerard N., Watson Ronald, (eds). Comprhensive Handbook of Iodine: Nutritional, Biochemical, Pathological and Therapeutic Aspects. Oxford: Academic, 2009,469-476
  7. Andersson M, De Benoist B, Delange F, Zupan J. Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2- years-old: conclusions and recommendations of the Technical Consultation. Public Health Nutr. 2007;10(12A):1606-1611. https://doi.org/10.1017/S1368980007361004
  8. Brent GA. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin Obstet Gynecol. 1997;40(1):3-15. https://doi.org/10.1097/00003081-199703000-00004
  9. Shields B, Hill A, Bilous M, Knight B, Hattersley AT, Bilous RW, et al. Cigarette smoking during pregnancy is associated with alterations in maternal and fetal thyroid function. J Clin Endocrinol Metab. 2009;94(2):570-574. https://doi.org/10.1210/jc.2008-0380
  10. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. https://doi.org/10.4158/EP12280.GL
  11. Tingi E, Syed AA, Kyriacou A, Mastorakos G, Kyriacou A. Benign thyroid disease in pregnancy: A state of the art review. J Clin Transl Endocrinol. 2016;23(6):37-49.
  12. Velasco I, Taylor P. Identifying and treating subclinical thyroid dysfunction in pregnancy: emerging controversies. Eur J Endocrinol. 2018;178(1):D1-D12. doi: 10.1530/EJE-17-0598.
  13. Stagnaro-Green A. Clinical guidelines: thyroid and pregnancy-time for universal screening? Nat Rev Endocrinol. 2017;13(4):192-194. doi: 10.1038/nrendo.2017.17.
  14. Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, Braverman LE, et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 2009; 200(3):260.e1-260.e6. https://doi.org/10.1016/j.ajog.2008.10.042
  15. Weeke J, Dybkjaer L, Granlie K, Eskjaer Jensen S, Kjaerulff E, Laurberg P, et al. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinologica. 1982;101(4):531-537.
  16. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3-126. https://doi.org/10.1089/105072503321086962
  17. Orito Y, Oku H, Kubota S, Amino N, Shimogaki K, Hata M, et al. Thyroid function in early pregnancy in Japanese healthy women: relation to urinary iodine excretion, emesis, and fetal and child development. J Clin Endocrinol Metab. 2009;94(5):1683-1688. https://doi.org/10.1210/jc.2008-2111
  18. Haddow JE, Knight GJ, Palomaki GE, McClain MR, Pulkkinen AJ. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen. 2004;11(4):170-174. https://doi.org/10.1258/0969141042467340
  19. Sapin R, D’Herbomez M, Schlienger JL. Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin Lab. 2004;50(9-10):581-584.
  20. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18(3):404-433. https://doi.org/10.1210/edrv.18.3.0300
  21. Persechini ML, Gennero I, Grunenwald S, Vezzosi D, Bennet A, Caron P. Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph function. Pituitary. 2015;18(4):461-464. https://doi.org/10.1007/s11102-014-0596-3
  22. Murillo-Llorente M, Fajardo-Montanana C, Perez-Bermejo M, Vila-Candel R, Gomez-Vela J, Velasco I. Intra-individual variability in TSH levels of healthy women during the first half of pregnancy. Endocrinol Diabetes Nutr. 2017;64(6):288-294. https://doi.org/10.1016/j.endinu.2017.04.002
  23. Chan SY, Vasilopoulou E, Kilby MD. The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metab. 2009;5(1):45-54. https://doi.org/10.1038/ncpendmet1026
  24. Reh A, Grifo J, Danoff A. What is a normal thyroid-stimulating hormone (TSH) level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization. Fertil Steril. 2010;94(7):2920-2922. https://doi.org/10.1016/j.fertnstert.2010.06.041
  25. Karmon AE, Batsis M, Chavarro JE, Souter I. Preconceptional thyroid-stimulating hormone levels and outcomes of intrauterine insemination among euthyroid infertile women. Fertil Steril. 2015;103(1):258-263. https://doi.org/10.1016/j.fertnstert.2014.09.035
  26. Korevaar TI, Steegers EA, Pop VJ, Broeren MA, Chaker L, de Rijke YB, et al. Thyroid autoimmunity impairs the thyroidal response to human chorionic gonadotropin: two populationbased prospective cohort studies. J Clin Endocrinol Metab. 2017;102(1):69-77.
  27. Thienpont LM, Beastall G, Christofides ND, Faix JD, Ieiri T, Miller WG, et al. Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum. Clin Chem Lab Med. 2007;45(7):934-936. https://doi.org/10.1515/CCLM.2007.155
  28. d'Herbomez M, Forzy G, Gasser F, Massart C, Beaudonnet A, Sapin R. Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. Clin Chem Lab Med. 2003;41(7):942-947. https://doi.org/10.1515/CCLM.2003.143
  29. Wald NJ. The triple test. Clin Chem, 2014;60(1):269-270. https://doi.org/10.1373/clinchem.2013.212050
  30. Laurberg P, Andersen SL. Endocrinology in pregnancy: Pregnancy and the incidence, diagnosing and therapy of Graves' disease. Eur J Endocrinol. 2016 ;175(5):R219-30. https://doi.org/10.1530/EJE-16-0410
  31. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol. 2006;107(2 Pt 1):337-341. https://doi.org/10.1097/01.AOG.0000197991.64246.9a
  32. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, et al. Report of the IFCC working group for standardization of thyroid function tests; part 1: thyroid-stimulating hormone. Clin Chem. 2010;56(6):902-911. https://doi.org/10.1373/clinchem.2009.140178
  33. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, et al. Report of the IFCC working group for standardization of thyroid function tests; part 2: free thyroxine and free triiodothyronine. Clin Chem. 2010;56(6):912-920. https://doi.org/10.1373/clinchem.2009.140194
  34. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, et al. Report of the IFCC working group for standardization of thyroid function tests; part 3: total thyroxine and total triiodothyronine. Clin Chem. 2010;56(6):921-929. https://doi.org/10.1373/clinchem.2009.140228
  35. Pop VJ, Biondi B, Wijnen HA, Kuppens SM, Lvader H. Maternal thyroid parameters, body mass index and subsequent weight gain during pregnancy in healthy euthyroid women. Clin Endocrinol (Oxf). 2013;79(4):577-583. https://doi.org/10.1111/cen.12177
  36. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543-2565. https://doi.org/10.1210/jc.2011-2803
  37. Moon HW, Chung HJ, Park CM, Hur M, Yun YM. Establishment of trimester-specific reference intervals for thyroid hormones in Korean pregnant women. Ann Lab Med. 2015;35(2):198-204. https://doi.org/10.3343/alm.2015.35.2.198
  38. Bestwick JP, John R, Maina A, Guaraldo V, Joomun M, Wald NJ, et al. Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs). Clin Chim Acta. 2014;430:33-37. doi: 10.1016/j.cca.2013.12.030.
  39. Ashoor G, Kametas NA, Akolekar R, Guisado J, Nicolaides KH. Maternal thyroid function at 11-13 weeks of gestation. Fetal Diagn Ther. 2010;27(3):156-163. https://doi.org/10.1159/000313301
  40. Moreno-Reyes R, Glinoer D, Van Oyen H, Vandevijvere S. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population based study. J Clin Endocrinol Metab. 2013;98(9):3694-3701. https://doi.org/10.1210/jc.2013-2149
  41. Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH. Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death. Thyroid. 2010;20(9):989-993. https://doi.org/10.1089/thy.2010.0058
  42. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Van der Wal MF, Bonsel GJ. Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clin Endocrinol (Oxf). 2007;66(6):765-770. https://doi.org/10.1111/j.1365-2265.2007.02803.x
  43. La'ulu SL, Roberts WL Second-trimester reference intervals for thyroid tests: the role of ethnicity. Clin Chem. 2007;53(9):1658-1664. https://doi.org/10.1373/clinchem.2007.089680
  44. Kachuei M, Jafari F, Kachuei A, Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2012;285(3):853-856. https://doi.org/10.1007/s00404-011-2040-5
  45. Monteleone P, Parrini D, Faviana P, Carletti E, Casarosa E, Uccelli A, et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol. 2011;66(2):108-114. https://doi.org/10.1111/j.1600-0897.2010.00961.x
  46. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. https://doi.org/10.1089/thy.2016.0457
  47. Medici M, Korevaar TI, Visser WE, Visser TJ, Peeters RP. Thyroid function in pregnancy: what is normal? Clin Chem. 2015;61(5):704-713. https://doi.org/10.1373/clinchem.2014.236646
  48. Pappa T, Anselmo J, Mamanasiri S, Dumitrescu AM, Weiss RE, Refetoff S. Prenatal diagnosis of resistance to thyroid hormone and its clinical implications. J Clin Endocrinol Metab. 2017;102(10):3775-3782. https://doi.org/10.1210/jc.2017-01251
  49. Roelfsema F, Veldhuis JD. Thyrotropin secretion patterns in health and disease. Endocr Rev. 2013;34(5):619-657. https://doi.org/10.1210/er.2012-1076
  50. Roti E, Bartalena L, Minelli R, Salvi M, Gardini E, Pistolesi A, et al. Circadian thyrotropin variations are preserved in normal pregnant women. Eur J Endocrinol. 1995;133(1):71-74. https://doi.org/10.1530/eje.0.1330071
  51. Robinson H, Robinson P, D'Emden M, Mahomed K. Management of thyroid disease in pregnancy-Room for improvement in the first trimester. Obstet Med. 2016;9(3):126-129. https://doi.org/10.1177/1753495X16629773
  52. Tingi E, Syed AA, Kyriacou A, Mastorakos G, Kyriacou A. Benign thyroid disease in pregnancy: A state of the art review. J Clin Transl Endocrinol. 2016;6:37-49. doi: 10.1016/j.jcte.2016.11.001.
  53. Budenhofer BK, Ditsch N, Jeschke U, Gartner R, Toth B. Thyroid (dys-)function in normal and disturbed pregnancy. Arch Gynecol Obstet. 2013;287(1):1-7. https://doi.org/10.1007/s00404-012-2592-z
  54. Bassols J, Prats-Puig A, Soriano-Rodriguez P, Garcia-Gonzalez MM, Reid J, Martinez-Pascual M, et al. Lower free thyroxin associates with a less favorable metabolic phenotype in healthy pregnant women. J Clin Endocrinol Metab. 2011;96(12):3717-3723. https://doi.org/10.1210/jc.2011-1784
  55. Faupel-Badger JM, Hsieh CC, Troisi R, Lagiou P, Potischman N. Plasma volume expansion in pregnancy: implications for biomarkers in population studies. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1720-1723. https://doi.org/10.1158/1055-9965.EPI-07-0311
  56. Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B. European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014;3(2):76-94. https://doi.org/10.1159/000362597
  57. McNeil AR, Stanford PE. Reporting thyroid function tests in pregnancy. Clin Biochem Rev. 2015;36(4):109-126.
  58. Yalamanchi S, Cooper DS. Thyroid disorders in pregnancy. Curr Opin Obstet Gynecol. 2015;27(6):406-415. https://doi.org/10.1097/GCO.0000000000000226
  59. Krassas G, Karras SN, Pontikides N. Thyroid diseases during pregnancy: a number of important issues. Hormones (Athens). 2015;14(1):59-69.
  60. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12(1):63-68. https://doi.org/10.1089/105072502753451986